{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:52:56Z","timestamp":1787662376057,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.juro.2015.10.066","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T16:21:44Z","timestamp":1445790104000},"page":"763-770","source":"Crossref","is-referenced-by-count":8,"title":["Evidence of Nonuniformity in Urothelium Barrier Function between the Upper Urinary Tract and Bladder"],"prefix":"10.1097","volume":"195","author":[{"given":"Nicholas A.","family":"Williams","sequence":"first","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Barnard","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Allender","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna L.","family":"Bowen","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gumbleton","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Harrah","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Boston Scientific, Urology and Women's Health Division, Marlborough, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Raja","sequence":"additional","affiliation":[{"name":"Department of Urology, University Hospital of Wales, Cardiff, Wales, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrishi B.","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Urology, University Hospital of Wales, Cardiff, Wales, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2015.10.066_bib1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","article-title":"European guidelines on upper tract urothelial carcinomas: 2013 update","volume":"63","author":"Roupr\u00eat","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2015.10.066_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2015.10.066_bib3","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1111\/bju.12025","article-title":"Prognosis is deteriorating for upper tract urothelial cancer: data for England 1985-2010","volume":"112","author":"Eylert","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2015.10.066_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1464-410X.2005.05402.x","article-title":"A\u00a0comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract","volume":"95","author":"Stewart","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2015.10.066_bib5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1464-410X.2012.11068.x","article-title":"Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review","volume":"110","author":"Cutress","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2015.10.066_bib6","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1111\/j.1464-410X.2012.11169.x","article-title":"Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience","volume":"110","author":"Cutress","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2015.10.066_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/0974-7796.115746","article-title":"Mitomycin C instillation following ureterorenoscopic laser ablation of upper urinary tract carcinoma","volume":"5","author":"Aboumarzouk","year":"2013","journal-title":"Urol Ann"},{"key":"10.1016\/j.juro.2015.10.066_bib8","first-page":"145","article-title":"Intracavitary immunotherapy and chemotherapy for upper urinary tract cancer: current evidence","volume":"15","author":"Carmignani","year":"2013","journal-title":"Rev Urol"},{"key":"10.1016\/j.juro.2015.10.066_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-5347(01)64015-1","article-title":"New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma","volume":"159","author":"Patel","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.066_bib10","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/S0022-5347(01)68157-6","article-title":"Adjuvant mitomycin C following endoscopic treatment of upper tract transitional cell carcinoma","volume":"158","author":"Keeley","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.066_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0022-5347(17)35473-3","article-title":"Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors","volume":"150","author":"Eastham","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.066_bib12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.eururo.2011.07.051","article-title":"Antegrade perfusion with bacillus Calmette-Gu\u00e9rin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?","volume":"60","author":"Giannarini","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2015.10.066_bib13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/14656561003657145","article-title":"Intravesical therapy for bladder cancer","volume":"11","author":"Williams","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.juro.2015.10.066_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ctrv.2009.12.005","article-title":"Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses","volume":"36","author":"Shelley","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.juro.2015.10.066_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1083\/jcb.26.1.25","article-title":"The fine structure of the transitional epithelium of rat ureter","volume":"26","author":"Hicks","year":"1965","journal-title":"J Cell Biol"},{"key":"10.1016\/j.juro.2015.10.066_bib16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1083\/jcb.200505035","article-title":"Cellular basis of urothelial squamous metaplasia","volume":"171","author":"Liang","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.juro.2015.10.066_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejcb.2004.12.011","article-title":"Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?","volume":"84","author":"Riedel","year":"2005","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.juro.2015.10.066_bib18","first-page":"3314","article-title":"Penetration of mitomycin C in human bladder","volume":"53","author":"Wientjes","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2015.10.066_bib19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0022-5347(01)66226-8","article-title":"The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up","volume":"155","author":"Tolley","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.066_bib20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1083\/jcb.151.5.961","article-title":"Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux","volume":"151","author":"Hu","year":"2000","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.juro.2015.10.066_bib21","doi-asserted-by":"crossref","first-page":"F1200","DOI":"10.1152\/ajprenal.00043.2002","article-title":"Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability","volume":"283","author":"Hu","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.juro.2015.10.066_bib22","first-page":"427","article-title":"Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies","volume":"140","author":"Moll","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.juro.2015.10.066_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0090-4295(77)90211-4","article-title":"Ileal substitute of ureter with reflux-plasty by terminal intussusception of bowel: animal experiments and clinical experience","volume":"9","author":"Tscholl","year":"1977","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.10.066_bib24","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-5347(17)40785-3","article-title":"A histochemical and immunohistochemical study of the autonomic innervation of the lower urinary tract of the female pig. Is the pig a good model for the\u00a0human bladder and urethra?","volume":"141","author":"Crowe","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.066_bib25","first-page":"265","article-title":"Histology and fine structure of the muscularis mucosae of the human urinary bladder","volume":"136","author":"Dixon","year":"1983","journal-title":"J Anat"},{"key":"10.1016\/j.juro.2015.10.066_bib26","doi-asserted-by":"crossref","first-page":"F242","DOI":"10.1152\/ajprenal.00307.2001","article-title":"Bladder permeability barrier: recovery from selective injury of surface epithelial cells","volume":"283","author":"Lavelle","year":"2002","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.juro.2015.10.066_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-5347(17)39897-X","article-title":"Bladder surface glycosaminoglycans: an epithelial permeability barrier","volume":"143","author":"Parsons","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.066_bib28","first-page":"3849","article-title":"Pharmacodynamics of mitomycin C in cultured human bladder tumors","volume":"51","author":"Schmittgen","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2015.10.066_bib29","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0022-5347(17)32493-X","article-title":"Correlation of human bladder tumor histoculture proliferation and sensitivity to mitomycin C with tumor pathobiology","volume":"152","author":"Schmittgen","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.066_bib30","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1023\/A:1016053729362","article-title":"Different pH dependency of mitomycin C activity in monolayer and three-dimensional cultures","volume":"13","author":"Yen","year":"1996","journal-title":"Pharm Res"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715050053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715050053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2015.10.066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:01:55Z","timestamp":1651204915000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2015.10.066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1016\/j.juro.2015.10.066"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2015.10.066","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}